Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 81 articles: HTML format

Single Articles

December 2022
1. ISHIHARA T, Iida O, Takahara M, Tsujimura T, et al
   Clinical course of patients with chronic limb-threatening ischemia developing COVID-19.
   J Cardiol. 2022;80:545-548.
   PubMed     Abstract available
   
   
   
2. KIRIGAYA H, Okada K, Hibi K, Maejima N, et al
   Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty.
   J Cardiol. 2022;80:511-517.
   PubMed     Abstract available
   
   
   
3. YAMAMOTO MH, Kondo S, Mizukami T, Yasuhara S, et al
   Rationale and design of the TACTICS registry: Optical coherence tomography guided primary percutaneous coronary intervention for patients with acute coronary syndrome.
   J Cardiol. 2022;80:505-510.
   PubMed     Abstract available
   
   
   
4. MIZUNO Y, Sakakura K, Jinnouchi H, Taniguchi Y, et al
   Impact of rotational atherectomy on the incidence of side branch compromise in calcified bifurcation lesions undergoing elective percutaneous coronary intervention.
   J Cardiol. 2022;80:518-524.
   PubMed     Abstract available
   
   
   
5. JAFFAR-KARBALLAI M, Haque A, Voller C, Elleithy A, et al
   Clinical and technical outcomes of robotic versus manual percutaneous coronary intervention: A systematic review and meta-analysis.
   J Cardiol. 2022;80:495-504.
   PubMed     Abstract available
   
   
   November 2022
6. NAKAO M, Inagaki Y, Hata T, Morioka Y, et al
   Clinical outcomes of endovascular therapy with vascular stents for central venous obstruction in hemodialysis patients.
   J Cardiol. 2022;80:469-474.
   PubMed     Abstract available
   
   
   
7. TROGER F, Reindl M, Tiller C, Lechner I, et al
   Prevalence and prognostic impact of mitral annular disjunction in patients with STEMI - A cardiac magnetic resonance study.
   J Cardiol. 2022;80:397-401.
   PubMed     Abstract available
   
   
   
8. OTA S, Nishiguchi T, Taruya A, Tanimoto T, et al
   Hyperglycemia and intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction.
   J Cardiol. 2022;80:456-461.
   PubMed     Abstract available
   
   
   October 2022
9. TOSHIMA T, Watanabe T, Goto J, Kobayashi Y, et al
   Impact of activities of daily living on percutaneous coronary intervention and acute and long-term mortality in patients with acute myocardial infarction: Yamagata AMI registry.
   J Cardiol. 2022;80:313-318.
   PubMed     Abstract available
   
   
   September 2022
10. SEKI T, Takeuchi M, Kawakami K
    Comparison of noninvasive follow-up testing in patients after percutaneous coronary intervention with drug-eluting stent implantation.
    J Cardiol. 2022;80:275-282.
    PubMed     Abstract available
    
    
    
11. NAKAHASHI T, Sakata K, Masuda J, Kumagai N, et al
    Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    J Cardiol. 2022;80:268-274.
    PubMed     Abstract available
    
    
    August 2022
12. KIMURA T, Akahori H, Tanaka T, Yanaka K, et al
    Impact of lipoprotein (a) on long-term outcome after percutaneous coronary intervention in the era of new generation drug-eluting stents.
    J Cardiol. 2022;80:179-183.
    PubMed     Abstract available
    
    
    
13. SHIMA Y, Kubo S, Ikuta A, Ohya M, et al
    Feasibility and safety of coronary catheterization with the distal radial approach for hemodialysis patients.
    J Cardiol. 2022;80:162-166.
    PubMed     Abstract available
    
    
    
14. MATSUMOTO I, Moriya S, Kurozumi M, Namba T, et al
    Simultaneous evaluation of fatty acid and triglycerides after percutaneous coronary intervention.
    J Cardiol. 2022;80:149-154.
    PubMed     Abstract available
    
    
    
15. TAKAHASHI K, Miura K, Shima Y, Okabe K, et al
    Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
    J Cardiol. 2022;80:155-161.
    PubMed     Abstract available
    
    
    July 2022
16. YAMAJI K, Iwanaga Y, Kawamura T, Fujita K, et al
    Plaque characteristics and prognosis in patients with peripheral arterial disease by angioscopic analysis.
    J Cardiol. 2022;80:94-100.
    PubMed     Abstract available
    
    
    June 2022
17. SATO T, Saito Y, Matsumoto T, Yamashita D, et al
    In-hospital adverse events in low-risk patients with acute myocardial infarction - Potential implications for earlier discharge.
    J Cardiol. 2022;79:747-751.
    PubMed     Abstract available
    
    
    May 2022
18. ZHANG S, Ji MH, Ding S, Wu Y, et al
    Inclusion of interleukin-6 improved performance of postoperative delirium prediction for patients undergoing coronary artery bypass graft (POD-CABG): A derivation and validation study.
    J Cardiol. 2022;79:634-641.
    PubMed     Abstract available
    
    
    
19. HROMADKA M, Motovska Z, Hlinomaz O, Kala P, et al
    The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study.
    J Cardiol. 2022;79:626-633.
    PubMed     Abstract available
    
    
    
20. HE HM, He C, Zhang SC, You ZB, et al
    Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.
    J Cardiol. 2022;79:618-625.
    PubMed     Abstract available
    
    
    April 2022
21. YAMAJI K, Mitsutake Y, Nakano M, Nakamura T, et al
    Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic.
    J Cardiol. 2022;79:455-459.
    PubMed     Abstract available
    
    
    
22. KITAHARA H, Yamazaki T, Hiraga T, Yamashita D, et al
    Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease.
    J Cardiol. 2022;79:559-563.
    PubMed     Abstract available
    
    
    
23. RUSSO JJ, Yan AT, Pocock SJ, Brieger D, et al
    Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry.
    J Cardiol. 2022;79:522-529.
    PubMed     Abstract available
    
    
    
24. SHIYOVICH A, Ovdat T, Klempfner R, Beigel R, et al
    Worse outcomes of ACS patients without versus with traditional cardiovascular risk factors.
    J Cardiol. 2022;79:515-521.
    PubMed     Abstract available
    
    
    
25. NISHIO R, Dohi T, Takeuchi M, Takahashi N, et al
    Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
    J Cardiol. 2022;79:509-514.
    PubMed     Abstract available
    
    
    March 2022
26. SHOJI K, Yanishi K, Kawamata H, Hori Y, et al
    New risk factors for early- and late-onset cardiac rupture in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention.
    J Cardiol. 2022;79:400-407.
    PubMed     Abstract available
    
    
    February 2022
27. MURAKAMI T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Complications related to veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction: VA-ECMO complications in AMI.
    J Cardiol. 2022;79:170-178.
    PubMed     Abstract available
    
    
    
28. MIR T, Uddin M, Shah A, Khan MZ, et al
    ST elevation myocardial infarction and kidney transplant: A large cohort study: STEMI and renal transplant.
    J Cardiol. 2022;79:270-276.
    PubMed     Abstract available
    
    
    
29. HE HM, Zhang SC, He C, You ZB, et al
    Association between neutrophil percentage-to-albumin ratio and contrast-associated acute kidney injury in patients without chronic kidney disease undergoing percutaneous coronary intervention.
    J Cardiol. 2022;79:257-264.
    PubMed     Abstract available
    
    
    January 2022
30. IMAMURA T
    Implication of early cardiac rehabilitation following acute myocardial infarction.
    J Cardiol. 2022;79:161-162.
    PubMed    
    
    
    
31. KOJIMA K, Komatsu S, Kakuta T, Fukamachi D, et al
    Aortic plaque burden predicts vascular events in patients with cardiovascular disease: The EAST-NOGA study.
    J Cardiol. 2022;79:144-152.
    PubMed     Abstract available
    
    
    
32. ASAKURA M, Hibi K, Shimizu W, Fujii K, et al
    Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease.
    J Cardiol. 2022;79:105-109.
    PubMed     Abstract available
    
    
    
33. MIR T, Qureshi WT, Uddin M, Shafi O, et al
    Non-ST elevation myocardial infarction and cardiac arrest: The United States Nationwide Emergency Department Sample.
    J Cardiol. 2022;79:98-104.
    PubMed     Abstract available
    
    
    
34. TAKAHARA M, Iida O, Soga Y, Kodama A, et al
    Features of asymptomatic contralateral limb in patients with chronic limb-threatening ischemia.
    J Cardiol. 2022;79:153-160.
    PubMed     Abstract available
    
    
    
35. TAKAHASHI T, Theodoropoulos K, Latib A, Okura H, et al
    Coronary physiologic assessment based on angiography and intracoronary imaging.
    J Cardiol. 2022;79:71-78.
    PubMed     Abstract available
    
    
    December 2021
36. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    PubMed     Abstract available
    
    
    
37. MATSUMOTO I, Moriya S, Kurozumi M, Namba T, et al
    Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention.
    J Cardiol. 2021;78:550-557.
    PubMed     Abstract available
    
    
    
38. LEE HF, Cheng YW, Peng JR, Hsu CY, et al
    Impact of chronic kidney disease on long-term outcomes for coronary in-stent restenosis after drug-coated balloon angioplasty.
    J Cardiol. 2021;78:564-570.
    PubMed     Abstract available
    
    
    
39. AKASHI R, Koga S, Yonekura T, Ikeda S, et al
    Cardio-ankle vascular index is associated with coronary plaque composition assessed with iMAP-intravascular ultrasound in patients with coronary artery disease.
    J Cardiol. 2021;78:502-508.
    PubMed     Abstract available
    
    
    November 2021
40. SETOYAMA K, Sonoda S, Naka Y, Okabe H, et al
    Right ventricular branch compromise after percutaneous coronary intervention and baseline chronic kidney disease: A high-risk combination associated with long-term prognoses in acute inferior myocardial infarction.
    J Cardiol. 2021;78:463-470.
    PubMed     Abstract available
    
    
    
41. KODAIRA M, Sawano M, Tanaka M, Kuno T, et al
    Female sex as an independent predictor of high bleeding risk among East Asian percutaneous coronary intervention patients: A sex difference analysis.
    J Cardiol. 2021;78:431-438.
    PubMed     Abstract available
    
    
    
42. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    PubMed     Abstract available
    
    
    October 2021
43. HATA Y, Iida O, Takahara M, Asai M, et al
    Saphenous vein size as a surrogate marker for mortality of patients with chronic limb-threatening ischemia undergoing endovascular therapy.
    J Cardiol. 2021;78:341-346.
    PubMed     Abstract available
    
    
    September 2021
44. SHIGETOSHI M, Hatanaka K, Ogawa A, Tabuchi I, et al
    Oxygen inhalation can selectively dilate pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension before balloon angioplasty.
    J Cardiol. 2021 Sep 22. pii: S0914-5087(21)00236.
    PubMed     Abstract available
    
    
    
45. SATO T, Saito Y, Matsumoto T, Yamashita D, et al
    Impact of CADILLAC and GRACE risk scores on short- and long-term clinical outcomes in patients with acute myocardial infarction.
    J Cardiol. 2021;78:201-205.
    PubMed     Abstract available
    
    
    
46. NISHI T, Okada K, Kitahara H, Kameda R, et al
    Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials.
    J Cardiol. 2021;78:224-229.
    PubMed     Abstract available
    
    
    
47. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed     Abstract available
    
    
    August 2021
48. HIOKI H, Kozuma K, Kinoshita Y, Nanasato M, et al
    Ischemic/bleeding event after short dual-antiplatelet therapy in patients with high bleeding risk: Sub-analysis of the MODEL U-SES study.
    J Cardiol. 2021;78:107-113.
    PubMed     Abstract available
    
    
    
49. HONDA S, Nishihira K, Kojima S, Takegami M, et al
    Characteristics and clinical outcomes of patients with de-escalation from prasugrel to clopidogrel after acute myocardial infarction - Insights from the prospective Japan Acute Myocardial Infarction Registry (JAMIR).
    J Cardiol. 2021;78:99-106.
    PubMed     Abstract available
    
    
    
50. NAKAMURA M, Iijima R
    Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.
    J Cardiol. 2021;78:91-98.
    PubMed     Abstract available
    
    
    July 2021
51. SUMINO Y, Yonetsu T, Ueno H, Nogami K, et al
    Clinical significance of neoatherosclerosis observed at very late phase between 3 and 7 years after coronary stent implantation.
    J Cardiol. 2021;78:58-65.
    PubMed     Abstract available
    
    
    June 2021
52. WONGSALAP Y, Kengkla K, Poolpun D, Saokaew S, et al
    Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand.
    J Cardiol. 2021;77:669-676.
    PubMed     Abstract available
    
    
    
53. MATSUDA J, Hamaya R, Hoshino M, Kanaji Y, et al
    FFR=1.0 flow changes after percutaneous coronary intervention.
    J Cardiol. 2021;77:634-640.
    PubMed     Abstract available
    
    
    
54. KOGA S, Ikeda S, Akashi R, Yonekura T, et al
    Serum soluble Klotho is inversely related to coronary artery calcification assessed by intravascular ultrasound in patients with stable coronary artery disease.
    J Cardiol. 2021;77:583-589.
    PubMed     Abstract available
    
    
    
55. TIEN YY, Huang HK, Shih MC, Tu YK, et al
    Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
    J Cardiol. 2021;77:576-582.
    PubMed     Abstract available
    
    
    
56. TOSHIMA T, Hirayama A, Watanabe T, Goto J, et al
    Unmet needs for emergency care and prevention of prehospital death in acute myocardial infarction.
    J Cardiol. 2021;77:605-612.
    PubMed     Abstract available
    
    
    May 2021
57. HOKAMA Y, Tanaka N, Takashima H, Kadota K, et al
    Insufficient recovery of fractional flow reserve even after optimal implantation of drug-eluting stents: 3-year outcomes from the FUJI study.
    J Cardiol. 2021;77:532-538.
    PubMed     Abstract available
    
    
    
58. UCHIDA Y, Shimoyama E, Hiruta N, Tabata T, et al
    Detection of early stage of human coronary atherosclerosis by angioscopic imaging of collagen subtypes.
    J Cardiol. 2021;77:452-456.
    PubMed     Abstract available
    
    
    
59. TERASHIMA M, Kaneda H, Honda Y, Shimura T, et al
    Current status of hybrid intravascular ultrasound and optical coherence tomography catheter for coronary imaging and percutaneous coronary intervention.
    J Cardiol. 2021;77:435-443.
    PubMed     Abstract available
    
    
    
60. TSUJIMURA T, Ishihara T, Okuno S, Iida O, et al
    Angioscopic assessments and clinical outcomes one year after polymer-free biolimus A9-coated coronary stent implantation.
    J Cardiol. 2021;77:457-464.
    PubMed     Abstract available
    
    
    April 2021
61. FUKASE T, Dohi T, Kato Y, Chikata Y, et al
    Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions.
    J Cardiol. 2021;77:417-423.
    PubMed     Abstract available
    
    
    
62. WATANABE S, Usui M
    Clinical features of ST-segment elevation myocardial infarction in patients receiving welfare public assistance in urban area of Japan.
    J Cardiol. 2021;77:404-407.
    PubMed     Abstract available
    
    
    
63. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed     Abstract available
    
    
    March 2021
64. HAGIWARA H, Fukuta H, Hashimoto H, Niimura T, et al
    A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims database.
    J Cardiol. 2021;77:285-291.
    PubMed     Abstract available
    
    
    
65. TOMITA H, Fujii T, Kise H, Oyama N, et al
    Percutaneous pulmonary artery debanding.
    J Cardiol. 2021;77:307-312.
    PubMed     Abstract available
    
    
    
66. NUIS RJ, Jadoon A, van Dalen BM, Dulfer K, et al
    Patient perspectives on left main stem revascularization strategies, the OPINION-2 study.
    J Cardiol. 2021;77:271-278.
    PubMed     Abstract available
    
    
    February 2021
67. ZHANG G, Zhao Z, Han Z, Gao Q, et al
    The predictive value of intraoperative transit-time flow measurement parameters for early graft failure in different target territories.
    J Cardiol. 2021;77:201-205.
    PubMed     Abstract available
    
    
    
68. MITARAI T, Tanabe Y, Akashi YJ, Maeda A, et al
    A novel risk stratification system "Angiographic GRACE Score" for predicting in-hospital mortality of patients with acute myocardial infarction: Data from the K-ACTIVE Registry.
    J Cardiol. 2021;77:179-185.
    PubMed     Abstract available
    
    
    
69. YAMAGUCHI T, Ueshima D, Utsunomiya M, Matsui A, et al
    Optimal cut-off value of preprocedural geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease.
    J Cardiol. 2021;77:109-115.
    PubMed     Abstract available
    
    
    
70. YOSHIOKA N, Takagi K, Morishima I, Morita Y, et al
    Association between discharge destination and mid-term mortality in octogenarian patients with ST-elevation myocardial infarction.
    J Cardiol. 2021;77:116-123.
    PubMed     Abstract available
    
    
    January 2021
71. NISHI H, Kodama K
    Author's reply: Can non-obstructive general angioscopy predict and aortic dissection before an attack?
    J Cardiol. 2021;77:106-108.
    PubMed    
    
    
    
72. KOJIMA K, Fukamachi D, Okumura Y
    Can non-obstructive general angioscopy predict an aortic dissection before an attack?
    J Cardiol. 2021;77:106-108.
    PubMed    
    
    
    
73. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    PubMed     Abstract available
    
    
    September 2020
74. NAKAMURA M, Yamashita T, Hayakawa A, Matsumoto T, et al
    Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
    J Cardiol. 2020 Sep 14. pii: S0914-5087(20)30293.
    PubMed     Abstract available
    
    
    
75. KIMURA M, Kohno T, Sawano M, Heidenreich PA, et al
    Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention.
    J Cardiol. 2020 Sep 1. pii: S0914-5087(20)30208.
    PubMed     Abstract available
    
    
    August 2020
76. MEHRAN R, Vogel B, Levy P
    Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
    J Cardiol. 2020 Aug 26. pii: S0914-5087(20)30258.
    PubMed     Abstract available
    
    
    May 2020
77. MINATSUKI S, Kodera S, Kiyosue A, Saito A, et al
    Balloon pulmonary angioplasty improves quality of life in Japanese patients with chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2020 May 8. pii: S0914-5087(20)30071.
    PubMed     Abstract available
    
    
    
78. AHN JH, Ahn Y, Jeong MH, Kim JH, et al
    Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
    J Cardiol. 2020;75:478-484.
    PubMed     Abstract available
    
    
    
79. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    PubMed     Abstract available
    
    
    
80. HIGASHIOKA D, Shiono Y, Kubo T, Kitabata H, et al
    The inter-study reproducibility of instantaneous wave-free ratio and angiography coregistration.
    J Cardiol. 2020;75:507-512.
    PubMed     Abstract available
    
    
    November 2019
81. ABE M, Masunaga N, Ishii M, Doi K, et al
    Current status of percutaneous coronary intervention in patients with atrial fibrillation: The Fushimi AF Registry.
    J Cardiol. 2019 Nov 3. pii: S0914-5087(19)30313.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: